Centre Proposes Trade Margin Cap to Reduce Anti-Cancer Drug Prices in India
The Indian government has informed the Supreme Court about hospitals charging high markups on anti-cancer drugs, ranging from 170% to over 700%, describing this as a malpractice due to patients' limited bargaining power and knowledge. To address this, the Centre proposes capping trade margins at 30% of the maximum retail price, aiming to reduce drug prices by 20-70% and save patients approximately Rs 2,500 crore annually. An expert committee is reviewing medicines for inclusion, with the National Pharmaceutical Pricing Authority set to issue revised price notifications.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 64%, Right 36%). Overall sentiment is positive (68/100). Lens Score 61/100.
Outlets measured: english, indiatoday. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
All 1 outlets scored close to centre on political lean. The real divergence here is in emphasis, not lean — compare the headlines below to see how each outlet chose to frame the same facts.
Sentiment was consistent across outlets (62–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
indiatoday broke this story on 23 Oct, 09:06 pm. Other outlets followed.